Registry of Lobbyists

Registration - Consultant

CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX&D) / ADRIENNE BLANCHARD, Consultant

Registration Information

Client name: CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX&D)
Lobbyist name: ADRIENNE BLANCHARD, Consultant
Initial registration start date: 2003-06-06
Registration status: Inactive
Registration Number: 776216-4141

Associated Communications

Total Number of Communication Reports: 0

Monthly communication reports in the last 6 months: 0

Version 1 of 11 (2003-06-06 to 2005-06-10)

Version 1 of 11 (2003-06-06 to 2005-06-10) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Registrant

Consultant lobbyist name: ADRIENNE BLANCHARD    Lobbyist business address
Consulting firm: GOWLING LAFLEUR HENDERSON LLP
160 ELGIN STREET
OTTAWA, ON  K1P 1C3
Canada
Position: LAWYER
Telephone number: 613-233-1781  
Fax number: 613-563-9869  
 
Former public office holder: N/A. Disclosure of this information was not a requirement prior to June 20, 2005.
Payment is contingent on the success of the undertaking: No

B. Information about Client

Client: CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX&D)
1220 - 55 METCALFE STREET
OTTAWA, ON  K1P 6L5
Canada
Telephone number: 613-236-0455
Fax number: 613-236-7919  
 
Client Representative: BRIGITTE NOLET
 
Parent: The client is not a subsidiary of any other parent companies.
Coalition: The client is not a coalition.
Subsidiary: The client does not have any subsidiaries that could be affected by the outcome of the undertaking.
Individual, organization or corporation: The client's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
 
Was the client funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No
 

C. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Health Canada (HC), Industry Canada, MEMBERS OF PARLIAMENT
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Presentations
 
Subject Matter: Areas of Concern: Health, Industry, Intellectual Property
 

Details Regarding the Identified Subject Matter

Categories Description
Legislative Proposal INDUSTRY COMMITTEE REVIEW OF AUTOMATIC INJUNCTION UNDER THE NOC REGULATIONS
Policy or Program PATENTED MEDICINES (NOTICE OF COMPLIANCE) REGULATIONS; AMENDMENTS TO FOOD AND DRUG REGULATIONS; DATA PROTECTION




Date Modified: